1. Home
  2. WAT vs KIM Comparison

WAT vs KIM Comparison

Compare WAT & KIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • KIM
  • Stock Information
  • Founded
  • WAT 1958
  • KIM 1958
  • Country
  • WAT United States
  • KIM United States
  • Employees
  • WAT N/A
  • KIM N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • KIM Real Estate Investment Trusts
  • Sector
  • WAT Industrials
  • KIM Real Estate
  • Exchange
  • WAT Nasdaq
  • KIM Nasdaq
  • Market Cap
  • WAT 17.4B
  • KIM 14.1B
  • IPO Year
  • WAT 1995
  • KIM 1991
  • Fundamental
  • Price
  • WAT $372.49
  • KIM $20.34
  • Analyst Decision
  • WAT Buy
  • KIM Buy
  • Analyst Count
  • WAT 12
  • KIM 12
  • Target Price
  • WAT $372.25
  • KIM $24.92
  • AVG Volume (30 Days)
  • WAT 685.5K
  • KIM 5.3M
  • Earning Date
  • WAT 11-04-2025
  • KIM 10-30-2025
  • Dividend Yield
  • WAT N/A
  • KIM 5.09%
  • EPS Growth
  • WAT 3.82
  • KIM 57.13
  • EPS
  • WAT 10.88
  • KIM 0.83
  • Revenue
  • WAT $3,105,638,000.00
  • KIM $2,123,057,000.00
  • Revenue This Year
  • WAT $7.12
  • KIM $4.86
  • Revenue Next Year
  • WAT $6.22
  • KIM $3.18
  • P/E Ratio
  • WAT $33.77
  • KIM $24.58
  • Revenue Growth
  • WAT 6.90
  • KIM 8.14
  • 52 Week Low
  • WAT $275.05
  • KIM $17.93
  • 52 Week High
  • WAT $423.56
  • KIM $25.83
  • Technical
  • Relative Strength Index (RSI)
  • WAT 70.28
  • KIM 32.24
  • Support Level
  • WAT $340.09
  • KIM $20.02
  • Resistance Level
  • WAT $382.02
  • KIM $21.84
  • Average True Range (ATR)
  • WAT 11.43
  • KIM 0.44
  • MACD
  • WAT 0.58
  • KIM -0.18
  • Stochastic Oscillator
  • WAT 71.99
  • KIM 14.58

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About KIM Kimco Realty Corporation (HC)

One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 567 shopping centers throughout major markets in the US, representing roughly 101 million square feet.

Share on Social Networks: